BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.2//EN
BEGIN:VTIMEZONE
TZID:W. Europe Standard Time
BEGIN:STANDARD
DTSTART:20251002T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=3;BYMINUTE=0;BYMONTH=10
TZNAME:W. Europe Standard Time
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:W. Europe Daylight Time
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:WHO launched a Task Force of AMR survivors in 2023 to give a pl
 atform for and elevate the voices of those with experience of complication
 s from drug resistant infections. This was done with an understanding that
  patient stories humanize a complex\, technical health and development cha
 llenge like AMR. The role of patients and survivors has been clearly recog
 nized in the political declaration of the UN General Assembly High-Level M
 eeting on AMR 2024. They are mentioned as key stakeholders and the politic
 al declaration calls for their engagement in developing meaningful solutio
 ns to the this global threat. In this regard\, it is important to widen th
 e scope of patient-led advocacy\, through engagement of a larger set of pa
 tient groups and networks around the world. This virtual roundtable will s
 erve as a platform to share experiences and will facilitate better underst
 anding of patient engagement strategies and opportunities to all critical 
 stakeholders involved in AMR interventions.
DTEND:20241121T150000Z
DTSTAMP:20260406T111948Z
DTSTART:20241121T133000Z
LOCATION:
SEQUENCE:0
SUMMARY:Widening the engagement of patient advocacy groups and networks in 
 Antimicrobial Resistance (AMR) action: A Global Roundtable (virtual)
UID:RFCALITEM639110711880361727
X-ALT-DESC;FMTTYPE=text/html:<p>WHO launched a Task Force of AMR survivors 
 in 2023 to give a platform for and elevate the voices of those with experi
 ence of complications from drug resistant infections. This was done with a
 n understanding that patient stories humanize a complex\, technical health
  and development challenge like AMR. The role of patients and survivors ha
 s been clearly recognized in the political declaration of the UN General A
 ssembly High-Level Meeting on AMR 2024. They are mentioned as key stakehol
 ders and the political declaration calls for their engagement in developin
 g meaningful solutions to the this global threat. In this regard\, it is i
 mportant to widen the scope of patient-led advocacy\, through engagement o
 f a larger set of patient groups and networks around the world. This virtu
 al roundtable will serve as a platform to share experiences and will facil
 itate better understanding of patient engagement strategies and opportunit
 ies to all critical stakeholders involved in AMR interventions.</p>
END:VEVENT
END:VCALENDAR
